Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PERRIGO COMPANY PLC

(PRGO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Perrigo Company plc
Perrigo Company plc is a provider of over the counter (OTC) health and wellness solutions that enables consumers to prevent or treat conditions that can be self-managed. The Company operates through two segments: Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises consumer self-care business (OTC, infant formula, and oral self-care categories, and contract manufacturing) in the United States (U.S), Mexico and Canada. CSCA segment products sold under brands, such as Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod and Firefly. The CSCI segment comprises consumer self-care business primarily branded in Europe and Australia, store brand business in the United Kingdom and parts of Europe and Asia. The CSCI segment primarily focuses on building local and regional brands sold through merchandisers, drug stores, pharmacies and e-commerce channels.

Number of employees : 11 500 people.
Sales per Business
20192020Delta
Consumer Self-Care Americas2 487.7051.4%2 693.0053.2% +8.25%
Consumer Self-Care International1 382.2028.6%1 395.2027.6% +0.94%
Prescription Pharmaceuticals967.5020%975.1019.3% +0.79%
USD in Million
Sales per region
20192020Delta
United States3 225.6066.7%3 441.1068% +6.68%
Europe1 312.4027.1%1 320.8026.1% +0.64%
All Other Countries276.005.7%271.605.4% -1.59%
Ireland23.400.5%29.800.6% +27.35%
USD in Million
Managers
Name Title Age Since
Murray Kessler President, Chief Executive Officer & Director 60 2018
Raymond Silcock CFO, Principal Accounting Officer & Executive VP 69 2019
Thomas Farrington Chief Information Officer & Executive VP 62 2015
Grainne Quinn Chief Medical Officer & Executive Vice President 50 2016
James Dillard Chief Scientific Officer & Executive VP 56 2019
Donal M. O'Connor Independent Director 69 2014
Geoffrey M. Parker Independent Director 55 2016
Theodore Rapp Samuels Independent Director 65 2017
Bradley A. Alford Independent, Director 63 2017
Jeffrey B. Kindler Independent Director 64 2017
Members of the board
Name Title Age Since
Rolf Classon Chairman 75 2018
Donal M. O'Connor Independent Director 69 2014
Geoffrey M. Parker Independent Director 55 2016
Theodore Rapp Samuels Independent Director 65 2017
Bradley A. Alford Independent, Director 63 2017
Jeffrey B. Kindler Independent Director 64 2017
Adriana Karaboutis Independent Director 58 2017
Murray Kessler President, Chief Executive Officer & Director 60 2018
Erica L. Mann Independent Director 61 2019
Katherine C. Doyle Independent Director 52 2020
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 133,549,064 131,948,735 98.8% 0 0.0% 98.8%
Shareholders
NameEquities%
T. Rowe Price Associates, Inc. (Investment Management) 23,192,628 17.4%
The Vanguard Group, Inc. 15,193,512 11.4%
SSgA Funds Management, Inc. 5,007,864 3.75%
Starboard Value LP 4,100,000 3.07%
Southeastern Asset Management, Inc. 4,038,200 3.02%
BlackRock Fund Advisors 3,525,099 2.64%
Carmignac Gestion SA 3,224,624 2.41%
The London Company of Virginia LLC 3,154,189 2.36%
Capital Research & Management Co. (Global Investors) 3,071,043 2.30%
York Capital Management Global Advisors LLC 3,070,023 2.30%
Company contact information
Perrigo Co. Plc
The Sharp Building
Hogan Place
Dublin 2

Phone : +353.1.709.4000
Web : http://www.perrigo.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Perrigo Company plc
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
PERRIGO COMPANY PLC3.62%6 261
JOHNSON & JOHNSON9.16%432 430
ROCHE HOLDING AG12.39%325 975
PFIZER, INC.13.23%218 198
ELI LILLY AND COMPANY44.60%209 276
NOVARTIS AG1.10%207 246
ABBVIE INC.10.30%199 548
MERCK & CO., INC.-5.21%195 475
NOVO NORDISK A/S33.81%188 446
ASTRAZENECA PLC15.78%155 197
BRISTOL-MYERS SQUIBB COMPANY10.17%149 020
AMGEN INC.7.74%139 433
SANOFI11.91%131 827
GLAXOSMITHKLINE PLC5.51%98 364
JIANGSU HENGRUI MEDICINE CO., LTD.-33.80%67 158
CHUGAI PHARMACEUTICAL CO., LTD.-25.00%65 930
ALLERGAN PLC0.97%63 659
BAYER AG6.32%60 766
TAKEDA PHARMACEUTICAL COMPANY LIMITED-1.20%53 101
DAIICHI SANKYO COMPANY, LIMITED-37.04%42 298
ASTELLAS PHARMA INC.19.95%33 619